Pharming Group NV
AEX:PHARM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharming Group NV
AEX:PHARM
|
NL |
|
LendLease Group
F:LLC
|
AU |
|
E
|
EVRAZ plc
XBER:EVZ
|
UK |
|
F
|
Fission Uranium Corp
F:2FU
|
CA |
|
F
|
Flowerkist Skin Care and Cosmetics Inc
OTC:FKST
|
US |
Shareholder Yield
Current shareholder yield for PHARM is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PHARM Price
Pharming Group NV
| Average Annual Return | 1.79% |
| Standard Deviation of Annual Returns | 30.19% |
| Max Drawdown | -52% |
| Market Capitalization | 782m EUR |
| Shares Outstanding | 706 250 000 |
| Percentage of Shares Shorted |
N/A
|
PHARM Return Decomposition
Main factors of price return
Stock Splits
PHARM's latest stock split occurred on Nov 23, 2016
The company executed a 805-for-799 stock split, meaning that for every 799 shares held, investors received 805 new shares.
Before the split, PHARM traded at 0.218 per share. Afterward, the share price was about 0.217.
The adjusted shares began trading on Nov 23, 2016. This was stock split number 2 in PHARM's history, following the previous one in Mar 5, 2013.
